Month: November 2017

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2024.03.12
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2023.11.13
Genomtec received positive evaluation of Grant in Oncology Diagnostics from the Polish Agency for Enterprise Development (PARP) and the European Funds for a Modern Economy program

2023.11.13
Genomtec S.A. expands its Genomtec ID platform to oncology and has filed a patent application specific to oncology diagnostics

Archive

2017.11.17

Genomtec is the owner of the European Union’s trademarks: GENOMTEC™ and SNAAT™

We are pleased to announce that the EUIPO (European Union Intellectual Property Office) granted to Genomtec the rights to the European ...
Read

Archive